Express Pharma - Express Pharma

Reportedly, 400+ delegates and 50 speakers were part of the summit

When patient safety is on the line, you need answers in minutes, not days. As supply chains grow more complex, the real risk isn’t…

Inspection conducted in November 2025; Establishment Inspection Report issued by US regulator

Transaction marks entry into global naturals market and sets up manufacturing and sales hub in Western Europe

Company scores 91 out of 100; included in Sustainability Yearbook 2026 for third consecutive year

Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million annual market sales

Findings released ahead of Shingles Action Week show low awareness and limited doctor-patient discussions on risk and vaccination

Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data with Indian participation

Initiative positions obesity as a chronic disease and highlights role of doctors in evidence-based care

Company secures final approval for ANDA across four strengths; cumulative USFDA ANDA approvals reach 235